BCL2 and non-small cell lung carcinoma: Similarly, miR-34a was shown to repress BCL2 expression, leading to sensitisation to sorafenib-induced apoptosis in hepatocellular carcinoma[28] and increased levels of apoptosis via the mitochondrial death cascade in non-small cell lung carcinoma (NSCLC) cells[40].